These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30141204)

  • 21. Dialysis central venous catheter types and performance.
    Gallieni M; Brenna I; Brunini F; Mezzina N; Pasho S; Giordano A
    J Vasc Access; 2014; 15 Suppl 7():S140-6. PubMed ID: 24817472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of dialysis catheter function.
    Gallieni M; Giordano A; Rossi U; Cariati M
    J Vasc Access; 2016 Mar; 17 Suppl 1():S42-6. PubMed ID: 26951903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
    Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
    Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central venous catheter-related thrombosis.
    Geerts W
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):306-11. PubMed ID: 25696870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.
    Cesaro S; Cavaliere M; Pegoraro A; Gamba P; Zadra N; Tridello G
    Ann Hematol; 2016 Apr; 95(5):817-25. PubMed ID: 26961934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
    Debourdeau P; Farge D; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Büller HR; Bounameaux H
    J Thromb Haemost; 2013 Jan; 11(1):71-80. PubMed ID: 23217208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Central venous catheter lock to prevent thrombosis and bacterial infection].
    Mandolfo S
    G Ital Nefrol; 2012; 29(3):301-7. PubMed ID: 22718454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of central venous catheter: prevention of thrombosis and bacteremia].
    Lomonte C; Basile C
    G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis Catheter-Related Central Venous Thrombosis: Clinical Approach to Evaluation and Management.
    Gunawansa N; Sudusinghe DH; Wijayaratne DR
    Ann Vasc Surg; 2018 Aug; 51():298-305. PubMed ID: 29772317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures.
    Cortelezzia A; Fracchiolla NS; Maisonneuve P; Moia M; Luchesini C; Ranzi ML; Monni P; Pasquini MC; Lambertenghi-Deliliers G
    Leuk Lymphoma; 2003 Sep; 44(9):1495-501. PubMed ID: 14565650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodialysis catheter thrombi: visualization and quantification of microstructures and cellular composition.
    Lucas TC; Tessarolo F; Veniero P; Caola I; Piccoli F; Haase A; Nollo G; Huebner R; Brunori G
    J Vasc Access; 2013; 14(3):257-63. PubMed ID: 23599143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
    Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
    Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging and management of complications of central venous catheters.
    Nayeemuddin M; Pherwani AD; Asquith JR
    Clin Radiol; 2013 May; 68(5):529-44. PubMed ID: 23415017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
    Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
    J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.